Pictet North America Advisors’s Zimmer Biomet ZBH Stock Holding History

Pictet North America Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,477	Closed	-$215K	–	132
2023 Q2	$215K	Sell	1,477 -782	-35%	-$106K	0.03%	124
2023 Q1	$292K	Sell	2,259 -2,634	-54%	-$331K	0.05%	111
2022 Q4	$624K	Sell	4,893 -312	-6%	-$36.2K	0.11%	89
2022 Q3	$544K	Hold	5,205	–	–	0.09%	101
2022 Q2	$547K	Buy	5,205 +76	+1%	+$9.02K	0.07%	104
2022 Q1	$656K	Sell	5,129 -1,166	-19%	-$141K	0.08%	92
2021 Q4	$776K	Buy	+6,295	New	+$824K	0.08%	88

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pictet North America Advisors's ZBH Position: Q3 2023 in Review

Pictet North America Advisors sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,477 shares — an estimated $215K sold.

Pictet North America Advisors first reported a position in ZBH in Q4 2021 and held it in 7 quarters. The position peaked at $776K in Q4 2021. 1,017 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Pictet North America Advisors reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Pictet North America Advisors sold 1,477 Zimmer Biomet shares in Q3 2023, an estimated $215K.
Pictet North America Advisors first reported a position in Zimmer Biomet in Q4 2021 and held it in 7 quarters.
Pictet North America Advisors's Zimmer Biomet position peaked at $776K in Q4 2021.
1,017 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Pictet North America Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.